Loandepot, Inc. current report, 20 April 2022

Business Context and Reporting Period

loanDepot, Inc. filed a Form 8-K covering management, board, stockholder-governance and equity-compensation changes announced or effective primarily on April 20–27, 2022. The filing is dated April 20, 2022 in the header and was signed April 26, 2022; it includes an April 26 announcement regarding the leadership transition.

Key Financial and Operating Metrics

This filing does not provide revenue, profit, cash flow, margins, debt, liquidity, operating results or other periodic financial metrics.

  • Frank Martell was appointed President and Chief Executive Officer, effective April 27, 2022, succeeding Anthony Hsieh.
  • Anthony Hsieh became Executive Chairman, effective April 27, 2022.
  • Martell’s initial annual base salary is $800,000, with a target annual bonus of 225% of base salary. For 2022, his target bonus is prorated, subject to a minimum of $900,000 and a maximum based on the applicable program.
  • Subject to Compensation Committee approval, Martell is to receive 1,000,000 restricted stock units, 3,000,000 performance stock units and options to purchase 1,000,000 Class A shares. The awards are generally subject to four-year time-based vesting or a five-year performance period, as applicable.
  • Beginning in 2023, Martell’s target annual equity grant is $4.4 million, subject to adjustment for performance and committee approval.
  • Hsieh’s base salary is $850,000 for the remainder of 2022 and $350,000 for 2023 and later years. His target bonus is 250% of base salary for 2022 and 100% for 2023 and later years.
  • The Board adopted a 2022 Inducement Plan reserving 5,000,000 Class A shares for qualifying equity awards.
  • John Lee is expected to receive annual director compensation of $250,000, payable 50% in cash and 50% in equity.

Material Changes Versus the Prior Comparable Period

  • Leadership changed from Hsieh as Chairman and CEO to Martell as President and CEO, with Hsieh continuing as Executive Chairman.
  • Hsieh’s prior executive employment agreement was amended and restated to reflect his new role and revised compensation.
  • The company entered into a new executive employment agreement with Martell, including substantial severance and equity provisions.
  • Mike Linton resigned from the Board, and John Lee was appointed as a Class I director and committee member. John Dorman resigned as Lead Independent Director but remained on the Board and its committees.
  • The company entered into an Amended and Restated Stockholders Agreement granting Hsieh-affiliated stockholders the right to designate a Class I director and certain preemptive rights, subject to exceptions.

Guidance, Outlook, Risks and Unusual Items

  • No company revenue, earnings or operational guidance is provided.
  • Martell’s employment is at will and includes confidentiality, noncompetition during employment, employee and customer nonsolicitation, and mutual nondisparagement covenants.
  • Specified termination scenarios may trigger significant cash severance, bonus payments, healthcare continuation and accelerated or extended equity vesting. A covered termination associated with a change in control may result in payment equal to three times base salary plus target bonus, in addition to other benefits.
  • Equity awards may be forfeited upon certain terminations, including termination for cause or resignation without good reason.
  • The Inducement Plan was adopted without shareholder approval under the NYSE inducement-award exception and may be used for equity awards that induce employment or, where permitted, relate to a merger or acquisition.
  • The filing states that there were no related-party arrangements with Martell requiring disclosure under Item 404(a) of Regulation S-K.

Important Facts for Investors to Verify

  • Review the full Martell employment agreement, including the performance conditions for 3,000,000 PSUs and the detailed termination and change-in-control provisions.
  • Review the amended Hsieh employment agreement to confirm the 2022 and subsequent-year bonus formulas and compensation terms.
  • Assess potential dilution from the 5,000,000-share Inducement Plan and the equity awards contemplated for Martell.
  • Review the Amended and Restated Stockholders Agreement for director-designation rights, preemptive rights and their effect on governance and future equity issuances.
  • Confirm the effective dates because the filing header, signature date and described announcement dates are not identical.